About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Liver Disease Clinical Trials | 200 Studies Recruiting

Clinical TrialsLiver Disease

Liver Disease Clinical Trials

Browse 200 clinical trials for liver disease. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 21-40 of 200 trials

Active not recruitingComparative Study Between Febuxostat Versus Vitamin E in Non-alcoholic Steatohepatitis Patients With HyperuricemiaThis study aims at evaluating and comparing the protective outcomes of using Febuxostat versus Vitamin E in Hyperuricemia non-alcoholic steatohepatitis patients without cirrhosis.NCT05574036·Tanta CompletedTreating Nonalcoholic Steatohepatitis With PioglitazoneNonalcoholic steatohepatitis (NASH) is a common liver disease that resembles alcoholic hepatitis but occurs in persons who drink little or no alcohol.NCT00062764·Bethesda, Maryland

Related Searches

cirrhosistrials nafldtrials

Data from ClinicalTrials.govTerms

UnknownPoint-of-care Ultrasound Screening and Assessment of Chronic Liver Diseases and NASHThe main objective of the study is to determine the diagnostic performances of an ultraportable diagnostic ultrasound system for the assessment of liver fibrosis severity in…NCT05120557

SuspendedGenomic Resources for Enhancing Available Therapies (GREAT1.0) StudyThis is a prospective, descriptive, observational research study designed to observe and document the clinical practice by domain experts, and how the knowledge of new findings…NCT04306939·Pittsburgh, Pennsylvania

Recruiting"Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases".Development of preclinical translational models for chronic liver tumors and diseases study, such as spheroids cultured in autologous medium and murine xenograft models to test…NCT04690972·Strasbourg

RecruitingDigoxin In NASH (CODIN)Nonalcoholic steatohepatitis (NASH) is a severe subtype of nonalcoholic fatty liver disease (NAFLD) which affects 1 in 3 Americans.NCT06588699·New Haven, Connecticut and 1 other

CompletedAccuracy of Imaging Techniques in Diagnosing Steatohepatitis and Fibrosis in NAFLD PatientsNon-alcoholic fatty liver disease (NAFLD) is a highly prevalent condition, and when fatty liver is associated with inflammation and hepatocellular injury (steatohepatitis), it can…NCT04785937·Reggio Emilia, RE

CompletedA Self Selected Population Study of Undiagnosed NAFLD and NASH, Using an Echosens FibroScan, in at Risk PopulationsLiver disease (NAFLD) and (NASH) are a rapidly increasing population health threat driven primarily by diet and lifestyle.NCT03726827·Texas City, Texas

Active not recruitingA Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and FibrosisA double-blind placebo controlled randomized Phase 3 study to determine if 80 or 100 mg of MGL-3196 as compared with placebo resolves NASH and/or reduces fibrosis on liver biopsy…NCT03900429·Birmingham, Alabama and 246 others

CompletedA Study of Efruxifermin in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) (Symmetry)This is a multi-center evaluation of efruxifermin (EFX) in a randomized, double-blind, placebo-controlled study in cirrhotic subjects with biopsy-proven F4 compensated NASH.NCT05039450·Chandler, Arizona and 48 others

Active not recruitingScreening for Chronic Liver Diseases in General PopulationImproving the care of patients with liver diseases in primary care and will allow patients with chronic liver disease to benefit from a course appropriate care.NCT06366425·Montpellier

CompletedEvaluation of the Effect of IHHT on Vascular Stiffness and Elasticity of the Liver Tissue in Patients With MS.The aim of this study is to assess the effect of interval hypoxy-hyperoxic training (IHHT) on the arterial stiffness and elasticity of the liver tissue in patients with metabolic…NCT04791397·Moscow

CompletedNon-invasive Ultrasound Diagnosis of Chronic Liver Diseases in Hepatology ConsultationEarly screening and monitoring of chronic liver diseases in hepatology practice has become crucial.NCT04782050·Pessac

UnknownA Study to Evaluate the Efficacy and Safety of Rencofilstat in Subjects With NASH and Advanced Liver FibrosisThis is a randomized, double-blind, placebo-controlled, parallel-dosing, multi-center study to evaluate the efficacy and safety of Rencofilstat as evidenced by histopathological…NCT05402371·Huntsville, Alabama and 40 others

CompletedA Study of CRV431 Dosed Once Daily in NASH Induced F2 and F3 SubjectsThis is a randomized, single-blind, placebo-controlled, once daily (QD) dose study of CRV431 in presumed NASH F2/F3 subjects.NCT04480710·Orange, California and 9 others

CompletedPK Study of Liquid Formulation of BIO89-100 in Subjects With NASH With Compensation CirrhosisThis is an open-label, single-dose study to evaluate the PK profile of the liquid SC formulation of BIO89-100 in approximately 8 male and female subjects with NASH with…NCT05022693·Chandler, Arizona

CompletedEfficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic SteatohepatitisThe purpose of this interventional study is to evaluate the efficacy and tolerability of docosahexaenoic acid (DHA), Vitamin E and Choline in children or adolescents with…NCT01934777·Rome, Rome, Italy

CompletedA Study to Evaluate the Safety and Efficacy of Cotadutide Given by Subcutaneous Injection in Adult Participants With Non-cirrhotic Non-alcoholic Steatohepatitis With FibrosisThe purpose of this study is to evaluate the safety and efficacy of cotadutide in participants with non-cirrhotic NASH with fibrosis.NCT05364931·Tucson, Arizona and 114 others

Active not recruitingSafety and Efficacy of Ketogenic Diet for Promoting Weight Loss in Obese Individuals With Compensated NASH CirrhosisThis is an open-label, randomized study comparing a monitored ketogenic diet intervention using standard ketogenic diet (SKD) and standard of care (SOC) dietary recommendations…NCT04383951·Indianapolis, Indiana

UnknownClinical Epidemiology of NAFLD in Children and AdolescentsBackground: Non-alcoholic fatty liver disease (NAFLD) is rapidly increasing alongside overweight and obesity, not only in adults but also in children and adolescents.NCT05526274·Mataró, Barcelona

PreviousPage 2 of 10Next